Decreased expression of SATB2 associates with tumor growth and predicts worse outcome in patients with clear cell renal cell carcinoma

10Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: SATB2 (special AT-rich sequence-binding protein 2) is a DNA-binding protein that is involved in transcriptional regulation and chromatin remodeling. SATB2 protein has been described as a promising novel marker in several human cancers. Patients and Methods: This study compared SATB2 expression in tumor and matched unchanged renal tissues collected from 57 patients with clear cell renal cell carcinoma (ccRCC). SATB2 mRNA levels were determined by quantitative polymerase chain reaction, while SATB2 protein expression was estimated by immunohistochemistry. Moreover, the associations between SATB2 expression in ccRCC samples and clinicopathological and survival data of the patients were investigated. Results: The mRNA level of SATB2 was lower in tumor tissues than in samples of corresponding unchanged kidney. Although the average immunoreactivity of SATB2 protein did not differ significantly between cancer cells and epithelial cells of proximal convoluted tubules, the decreased SATB2 expression in tumor specimens inversely correlated with the size of primary tumor and predicted worse patients’ outcome. Conclusion: The results of the presented study suggest the tumor-suppressing function of SATB2 and that the expression level of this protein can be considered a potential prognostic factor in ccRCC.

References Powered by Scopus

Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>-ΔΔC</sup>T method

149839Citations
N/AReaders
Get full text

Prognostic significance of morphologic parameters in renal cell carcinoma

2462Citations
N/AReaders
Get full text

Renal cell carcinoma

1379Citations
N/AReaders
Get full text

Cited by Powered by Scopus

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma

13Citations
N/AReaders
Get full text

Micrornas possibly involved in the development of bone metastasis in clear-cell renal cell carcinoma

10Citations
N/AReaders
Get full text

IKBKB expression in clear cell renal cell carcinoma is associated with tumor grade and patient outcomes

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sliwinska-Jewsiewicka, A., Kowalczyk, A. E., Krazinski, B. E., Godlewski, J., Kwiatkowski, P., Kiewisz, J., … Kmiec, Z. (2018). Decreased expression of SATB2 associates with tumor growth and predicts worse outcome in patients with clear cell renal cell carcinoma. Anticancer Research, 38(2), 839–846. https://doi.org/10.21873/anticanres.12292

Readers over time

‘18‘19‘20‘22‘23‘2401234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

50%

Professor / Associate Prof. 2

25%

Researcher 2

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

56%

Agricultural and Biological Sciences 2

22%

Biochemistry, Genetics and Molecular Bi... 2

22%

Save time finding and organizing research with Mendeley

Sign up for free
0